Mizuho Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $14

Benzinga Newsdesk www.benzinga.com Positive 82.3%

Neg 0% Neu 0% Pos 82.3%

Mizuho analyst Joseph Catanzaro initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Outperform rating and announces Price Target of $14.